| Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169) |
|---|
| 02/05/2009 | WO2009017161A1 Inhibitory agent for inflammatory cytokine |
| 02/05/2009 | WO2009016565A1 Tricyclic compounds for the treatment of inflammatory disorders |
| 02/05/2009 | WO2009016390A1 Anti-inflammatory composition |
| 02/05/2009 | WO2009016241A1 5-phenyl-isoxazole-3-carboxamide derivatives as trpv1 modulators |
| 02/05/2009 | WO2009015812A2 Prodrugs of 2-amino-6- ( { [2- (4-chlorphenyl) -1, 3-thiaz0l-4-yl] methyl}thio) -4- [4- ( 2 -hydroxyethoxy) phenyl] pyridin-3, 5-dicarbonitrile |
| 02/05/2009 | WO2008153394A3 Novel anti-inflammatory pro-drugs |
| 02/05/2009 | WO2008144019A3 Suppression of allergic inflammation by ascaris heme-binding protein (hbp) |
| 02/05/2009 | WO2008135826A3 2 -pyridine carboxamide derivatives as sodium channel modulators |
| 02/05/2009 | WO2008108957A3 Piperidinyl-piperidine and piperazinyl-piperidine for use in the treatment of diabetes or pain |
| 02/05/2009 | WO2003099808A8 Substituted heterocyclic compounds and methods of use |
| 02/05/2009 | US20090036530 Crystalline acid of lipoxin A4 analogs and method of making |
| 02/05/2009 | US20090036523 Prodrugs of cannabidiol, compositions comprising prodrugs of cannabidiol and methods of using the same |
| 02/05/2009 | US20090036519 Peroxisome proliferator activated receptor ligand and process for producing the same |
| 02/05/2009 | US20090036516 Compounds for treating metabolic syndrome |
| 02/05/2009 | US20090036510 P-3-(trifluoromethyl)-5-(p-tolyl)pyrazol-1-yl)benzenesulonylaminooxy- compounds; more effective than celecoxib and have fewer gastrointestinal and cardiovascular side effects; 4-(5-p-methyl-phenyl)-3-trifluoromethyl-pyrazol-1-yl)-benzenesulfonic acid intermediate |
| 02/05/2009 | US20090036495 Combinations Comprising Alpha-2-Delta Ligands and Ep4 Receptor Antagonists |
| 02/05/2009 | US20090036491 Transdermal pharmaceutical delivery compositions |
| 02/05/2009 | US20090036486 3-(2',2'-Dimethylpropanoylamino)tetrahydropyridin-2-one for prevention or treatment of inflammatory disorders, autoimmune diseases |
| 02/05/2009 | US20090036484 Use of Unsaturated Quionoline or Naphtalene Derivatives as Medicaments |
| 02/05/2009 | US20090036482 Imidazopyridine-derivatives as inductible no-synthase inhibitors |
| 02/05/2009 | US20090036472 Azabicyclo derivatives as anti-inflammatory agents |
| 02/05/2009 | US20090036471 Triazolopyrimidine Derivatives As Glycogen Synthase Kinase 3 Inhibitors |
| 02/05/2009 | US20090036429 Hydroxypiperidine Derivatives and Uses Thereof |
| 02/05/2009 | US20090036423 Immunosuppresant compounds and compositions |
| 02/05/2009 | US20090036419 Compounds useful as raf kinase inhibitors |
| 02/05/2009 | US20090036412 Methods and Compositions for Inhibition of Angiogenesis |
| 02/05/2009 | US20090036411 Modulation of cell fates and activities by phthalazinediones |
| 02/05/2009 | US20090036406 Injection |
| 02/05/2009 | US20090036374 Hepatocyte growth factor receptor splice variants and methods of using same |
| 02/05/2009 | US20090036360 Medicament containing activated antithrombin iii |
| 02/05/2009 | US20090035752 detecting whether CpG sequences in a region from base 374 to base 592 in a DR3 gene promoter region obtained from synovial cells or synovial infiltrating lymphocytes of the human subject are methylated or not |
| 02/05/2009 | US20090035402 Method for Extracting Plants of the Genus Pelargonium, Extract Produced According to Said Method, and Use Thereof |
| 02/05/2009 | US20090035395 Spondias mombin l. extract and methods of extracting and using such extract |
| 02/05/2009 | US20090035314 Method and pharmaceutical composition for preventing or treating diseases associated with inflammation |
| 02/05/2009 | US20090035313 Compounds |
| 02/05/2009 | US20090035264 Aerosolizing dry powder of interleukin-4 receptor with carbohydrage, lipid, buffer, peptide, protein, Group II metal, or oligopeptide excipient; small aerodynamic particle size; dispersion into gas stream to make inhalant; high dispersibilities |
| 02/05/2009 | DE19963179B4 Substituierte 1- und 2-Naphthol-Mannichbasen Substituted 1- and 2-naphthol Mannich bases |
| 02/05/2009 | CA2698170A1 Prodrugs of 2-amino-6- ( { [2- (4-chlorphenyl) -1, 3-thiaz0l-4-yl] methyl}thio) -4- [4- ( 2 -hydroxyethoxy) phenyl] pyridin-3, 5-dicarbonitrile |
| 02/05/2009 | CA2695257A1 Anti-inflammatory composition |
| 02/05/2009 | CA2694663A1 5-phenyl-isoxazole-3-carboxamide derivatives as trpv1 modulators |
| 02/05/2009 | CA2694504A1 (2s,3r)-n-(2-((3-pyridinyl)methyl)-1-azabicyclo[2.2.2]oct-3-yl)benzofuran-2-carboxamide, novel salt forms, and methods of use thereof |
| 02/05/2009 | CA2694325A1 Prodrugs of cannabidiol, compositions comprising prodrugs of cannabidiol and methods of using the same |
| 02/05/2009 | CA2693390A1 Derivatives of n-(arylamino) sulfonamides including polymorphs as inhibitors of mek as well as compositions, methods of use and methods for preparing the same |
| 02/04/2009 | EP2020409A1 New piperidinyl derivatives as modulators of chemokine receptor activity |
| 02/04/2009 | EP2020408A1 Pyrrole substituted 2-indolinone protein kinase inhibitors |
| 02/04/2009 | EP2020243A1 Topically applicable pharmaceutical preparation |
| 02/04/2009 | EP2020239A1 Use of IL-174 agonists for treating infectious diseases |
| 02/04/2009 | EP2019835A1 Oligonucleotides affecting expression of phosphodiesterases |
| 02/04/2009 | EP2019834A1 Ectonucleotidase inhibitors |
| 02/04/2009 | EP2019826A1 Thiophene-carboxamides useful as inhibitors of protein kinases |
| 02/04/2009 | EP2019682A1 Cytokine mediating composition |
| 02/04/2009 | EP2019666A2 Pharmaceutical preparations for transdermal use |
| 02/04/2009 | EP1542976B1 Substituted 4-(indazol-3-yl)phenols as estrogen receptor (er) ligands and their use in the treatment of inflammatory diseases |
| 02/04/2009 | EP1492773B1 4-(heterocyclyl)-benzenesulfoximine compounds for the treatment of inflammation |
| 02/04/2009 | EP0821589B1 Compositions and methods to prevent toxicity induced by nonsteroidal antiinflammatory drugs |
| 02/04/2009 | CN101360824A Lipopolysaccharide- or lipid A-binder, and novel peptide |
| 02/04/2009 | CN101360750A Method of modulating stress-activated protein kinase system |
| 02/04/2009 | CN101360738A Compositions and methods for modulating gated ion channels |
| 02/04/2009 | CN101358225A Method for preparing high sialic acid content immune globulin antibody and application |
| 02/04/2009 | CN101357204A Quality control method of traditional Chinese medicine preparation for treating pain |
| 02/04/2009 | CN101357168A Medicinal wine for treating rheumatic arthritis |
| 02/04/2009 | CN101357163A External medicine for treating wind-cold type common cold and preparation method thereof |
| 02/04/2009 | CN101357162A Traditional Chinese medicine capable of inducing menstruation and removing bloodstasis |
| 02/04/2009 | CN101357154A Chinese herbal medicine composition with bacteriostasis, anti-inflammation hemostasia effect |
| 02/04/2009 | CN101357124A Medicine for treating osteoarthritis |
| 02/04/2009 | CN101357122A Use of carbon monoxide released substance in preparing medicine for treating pyemia |
| 02/04/2009 | CN100459776C Access parameter adaptation and packet data resource management by utilizing detailed mobile status information |
| 02/04/2009 | CN100457908C Recombinant stratum corneum chymotryptic enzyme (SCCE) |
| 02/04/2009 | CN100457777C Leucine-based motif and clostridial neurotoxins |
| 02/04/2009 | CN100457753C N-[5-[[[5-alkyl-2-oxazolyl]methyl]thio]-2-thiazolyl] carboxamide inhibitors of cyclin dependent kinases |
| 02/04/2009 | CN100457737C Quinolyl amide derivative and its preparation process and use |
| 02/04/2009 | CN100457735C Therapeutic agents useful for treating pain |
| 02/04/2009 | CN100457184C Multi-stage oral drug controlled-release system |
| 02/04/2009 | CN100457151C Chinese goldthread soft capsule for clearing away adverse lung energy and its preparation process |
| 02/04/2009 | CN100457117C Application of woodruff acid with acetyl being removed in preparing medicine for treating rheumatoid arthritis |
| 02/04/2009 | CN100457088C Pharmaceutical composition comprising lipids comprising polar and nonpolar moiety parts |
| 02/03/2009 | US7485730 Pharmaceutical compounds |
| 02/03/2009 | US7485724 2,4-pyrimidinediamine compounds and their uses |
| 02/03/2009 | US7485713 Polypeptides comprising growth hormone receptor extracellular domain and glycosylphosphatidylinositol |
| 02/03/2009 | US7485697 Nucleotide sequences coding receptor for advanced glycation endproducts (RAGE) for identifying modulators for treatment and prevention of cell proliferative and cardiovascular disorders |
| 02/03/2009 | US7485660 For selectively modulating the activation, repression, agonism and antagonism effects of the glucocorticoid receptor in a patient; for therapy and prophylaxis of obesity, diabetes, depression, neurodegeneration or an inflammatory disease |
| 02/03/2009 | US7485655 2-Aminothiazole allosteric enhancers of A1 adenosine receptors |
| 02/03/2009 | US7485639 Well tolerated; intracellularly increasing cAMP; antiasthmatics, antiinflammatories: regulation of eosinophiles activation and degranulation |
| 02/03/2009 | US7485638 Pyrimidine compounds |
| 02/03/2009 | US7485628 Inhibition of STAT-1 |
| 02/03/2009 | US7485456 Drug screening for a molecule capable of binding to NIK (nuclear factor kappa B inducing kinase); DNA sequence encoding a protein capable of binding to a tumor necrosis factor receptor-associated factor (TRAF) molecule, TRAF-binding proteins, isoforms, analogs, fragments and derivatives; gene expression |
| 02/03/2009 | US7485327 For use in pharmaceuticals, dietetics and/or cosmetics; anticancer agents; for treatment of vision defects and periodontal disease |
| 02/03/2009 | US7485301 Complexing, therapy, prophylaxis, medical diagnosis; antibodies, antigen binding to chemokine |
| 02/03/2009 | US7485285 Delivery of antidepressants through an inhalation route |
| 02/03/2009 | CA2425164C (4-acylaminopiperidin-1-yl)acetamides as neurokinin antagonists |
| 02/03/2009 | CA2420040C New phenylalanine derivatives |
| 02/03/2009 | CA2354042C Bioflavonoids, anthocyanins and phenolic compounds from cherries for inhibiting inflammation |
| 02/03/2009 | CA2275321C Medical composition and use thereof for the manufacture of a topical barrier formulation, a uv-radiation absorbing formulation, or an antiviral, antifungal, or antiinflammatory formulation |
| 01/29/2009 | WO2009015000A1 Pyrazole urea derivatives used as kinase inhibitors |
| 01/29/2009 | WO2009014263A1 Agent for treatment of ophthalmia containing interleukin-6 receptor inhibitor as active ingredient |
| 01/29/2009 | WO2009014127A1 Composition for prevention or treatment of disease associated with the production of autoantibody |
| 01/29/2009 | WO2009014100A1 p27 PROTEIN INDUCER |
| 01/29/2009 | WO2009014097A1 Novel histidine derivative |
| 01/29/2009 | WO2009013885A1 Inhibitor of the differentiation of t cells into th1 cells |
| 01/29/2009 | WO2009013299A2 Novel bradykinin b1 antagonists |